EQT to acquire Aldevron

EQT has agreed to acquire a majority stake in Fargo, North Dakota-based Aldevron, a producer of nucleic acids, proteins, and antibodies. No financial terms were disclosed. TA Associates will retain a minority stake in Aldevron. Morgan Stanley served as financial adviser to EQT on the deal while Goldman Sachs did likewise for TA Associates.

DealsNorth AmericaUSHealthcareBriefs